Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors
Current Chairman, David Drutz, M.D., remains Chairman of Compensation Committee and Member of the Board GAITHERSBURG, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the …